A Randomized, Controlled Trial Comparing the Effect of Exenatide, Sitagliptin or Glimepiride on Functional beta-Cell Mass in Patients With Impaired Fasting Glucose or Early Type 2 Diabetes.
Phase of Trial: Phase II
Latest Information Update: 08 Dec 2017
At a glance
- Drugs Exenatide (Primary) ; Sitagliptin (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 01 Nov 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Nov 2008 New trial record.